Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

Non-Vitamin K Antagonist Oral Anticoagulants

(2014) Gregory Y.H Lip et al.   CHEST

Bleeding and antidotes in new oral anticoagulants

(2013) Ammar Majeed et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

(2013) Hein Heidbuchel et al.   EUROPACE

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

(2013) Pilar Gallego et al.   THROMBOSIS AND HAEMOSTASIS

General mechanisms of coagulation and targets of anticoagulants (Section I)

(2013) Steen Husted et al.   THROMBOSIS AND HAEMOSTASIS

Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)

(2013) Steen Husted et al.   THROMBOSIS AND HAEMOSTASIS

Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

(2013) Raffaele Caterina et al.   THROMBOSIS AND HAEMOSTASIS

New Antithrombotic Drugs

(2012) Jeffrey I. Weitz et al.   CHEST

Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial

(2012) A. J. Camm et al.   EUROPACE

New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes

(2012) Raffaele De Caterina et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Oral anticoagulation use by patients with atrial fibrillation in Germany

(2012) Antje Groth et al.   THROMBOSIS AND HAEMOSTASIS